• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMR 5.21% 45.5¢

IMRICOR MEDICAL SYSTEMS INC.

Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging... Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMR
News: IMR Imricor Medical Systems Says Visabl-AFL Trial For Us FDA Approval Receives Final Approval
10:20 0 35
10:20 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  35 
IMR 09:39 0 102
09:39 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  102 
IMR 08/05/24 0 86
TRENDING NEWS

What does it take to get a new drug to market in Australia?

NEWS
09 May 2024
08/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  86 
IMR 02/05/24 0 123
02/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  123 
IMR 30/04/24 0 134
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  134 
IMR 30/04/24 0 113
30/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  113 
IMR 23/04/24 0 119
23/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  119 
IMR 12/04/24 0 124
12/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  124 

See All Discussions arrow Created with Sketch.

Timeline

Swissmedic Approval for VISABL-AFL Clinical Trial at CHUV
09 May 09:19
 
Appendix 3Y - PM
08 May 11:30
 
Release from Voluntary Escrow
02 May 08:25
 
Q1 CY24 Quarterly Results Investor Presentation
30 Apr 08:47
 
Imricor Q1 CY24 Quarterly Activities Report and Appendix 4C
30 Apr 08:45
 
Imricor Q1 CY24 Webinar Notification
23 Apr 08:49
 
View More arrow Created with Sketch.
(20min delay)
Last
45.5¢
Change
-0.025(5.21%)
Mkt cap ! $92.16M
Open High Low Value Volume
48.5¢ 48.8¢ 45.5¢ $121.9K 254.1K

Buyers (Bids)

No. Vol. Price($)
2 15999 45.5¢
 

Sellers (Offers)

Price($) Vol. No.
48.0¢ 9676 1
View Market Depth
Last trade - 16.10pm 09/05/2024 (20 minute delay) ?
Last
47.0¢
  Change
-0.025 ( 3.09 %)
Open High Low Volume
48.0¢ 49.0¢ 47.0¢ 12201
Last updated 14.43pm 09/05/2024 ?
IMR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.